Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Maini

Showing results (321-330 of 337) with videos related to

Pageof 34
Sort By:
The Quarterly Journal of Medicine|October 1, 1990
Dialysis arthropathy: a clinical, biochemical, radiological and histological study of 36 patientsD Sethi, T C Morgan, E A Brown, et al.
Arthritis and Rheumatism|September 2, 2006
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexateR N Maini, P C Taylor, J Szechinski, et al.
Lancet (London, England)|October 22, 1994
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritisM J Elliott, R N Maini, M Feldmann, et al.
Arthritis and Rheumatism|April 9, 2005
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy studyJ S Smolen, C Han, M Bala, et al.
The American Journal of Pathology|November 1, 1990
Antibodies to the mycobacterial 65-kd heat-shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritisE R de Graeff-Meeder, M Voorhorst, W van Eden, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritisP Charles, M J Elliott, D Davis, et al.
Arthritis and Rheumatism|September 29, 1998
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritisR N Maini, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|April 13, 2004
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexateR N Maini, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|March 1, 1997
Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blottingJ S Smolen, B Butcher, M J Fritzler, et al.
Pageof 34

Showing results (321-330 of 337) with videos related to

Sort By:
Pageof 34
The Quarterly Journal of Medicine|October 1, 1990
Dialysis arthropathy: a clinical, biochemical, radiological and histological study of 36 patientsD Sethi, T C Morgan, E A Brown, et al.
Arthritis and Rheumatism|September 2, 2006
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexateR N Maini, P C Taylor, J Szechinski, et al.
Lancet (London, England)|October 22, 1994
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritisM J Elliott, R N Maini, M Feldmann, et al.
Arthritis and Rheumatism|April 9, 2005
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy studyJ S Smolen, C Han, M Bala, et al.
The American Journal of Pathology|November 1, 1990
Antibodies to the mycobacterial 65-kd heat-shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritisE R de Graeff-Meeder, M Voorhorst, W van Eden, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritisP Charles, M J Elliott, D Davis, et al.
Arthritis and Rheumatism|September 29, 1998
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritisR N Maini, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|April 13, 2004
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexateR N Maini, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|March 1, 1997
Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blottingJ S Smolen, B Butcher, M J Fritzler, et al.
Pageof 34